Profound Medical Corp. to Present at he 29th Annual Piper Jaffray Healthcare Conference
November 14, 2017, Press Release
Profound Medical Corp. Announces Third Quarter 2017 Financial Results
November 7, 2017, Press Release
Profound Medical Corp. Announces Expanded Clinical Use of TULSA-PRO® in Prostate Care to Include BPH
November 6, 2017, Press Release
Profound Medical Corp. to present at the 2017 Canaccord Genuity Medical Technologies & Diagnostics Form
October 26, 2017, Press Release
Profound Medical Corp. to Release Third Quarter 2017 Financial Results on November 7, 2017 – Conference Call to Follow
October 25, 2017, Press Release
Profound Medical Corp. Announces Closing of $10 Million “Bought Deal” Financing
September 20, 2017, Press Release
Prostate cancer cure: Pinckney man part of breakthrough study
September 20, 2017, LivingstonDaily
Profound Makes Leap to Platform Company from Prostate Product
September 5, 2017, BioTuesdays
Profound Medical Corp. Announces $10 Million “Bought Deal” Financing
August 24, 2017, Press Release
Profound Medical Announces Second Quarter 2017 Financial Results
August 23, 2017, Press Release
Profound Medical Corp. to Release Second Quarter 2017 Financial Results on August 23, 2017 – Conference Call to Follow
August 9, 2017, Press Release
Groundbreaking Prostate Cancer Study Enters Its Final Phase
August 7, 2017, Beaumont Health, News Release
Profound Medical Corp. Completes Acquisition of Royal Philips’ Sonalleve MR-HIFU Business
July 31, 2017, Press Release
Profound Medical Corp. Announces Definitive Agreement with Royal Philips to Expand Collaboration and Acquire Sonalleve MR-HIFU Business
June 30, 2017, Press Release
First Hoosier prostate cancer patients treated with MRI-guided transurethral ultrasound
June 7, 2017, Indiana University School of Medicine – Research Updates
Profound Medical Corp. Announces Annual Meeting of Shareholders Voting Results
May 24, 2017, Press Release
Profound Posts First-time Revenue in Q1; TACT trial 25% enrolled
May 9, 2017, BioTuesdays
Profound Medical Corp. Announces First Quarter 2017 Financial Results
May 9, 2017, Press Release
Profound Medical to Present at the CIBC Technology & Innovation Conference 5.0
May 3, 2017, Press Release
Profound Medical Corp. to Release First Quarter 2017 Financial Results on May 9, 2017 – Conference Call to Follow
April 25, 2017, Press Release
Profound Medical Corp. Obtains DTC Eligibility for its Common Shares in the U.S.
April 18, 2017, Press Release
Profound Medical’s TULSA-PRO pilot OUS launch: paving the way for global growth
March 28, 2017, BioTuesdays
Profound Medical Corp. Announces First Paid Procedure Using TULSA-PRO® System
March 27, 2017, Press Release
Profound Medical Corp. Announces Management Change
March 24, 2017, Press Release
Profound Medical Corp. and Philips Announce first TULSA-PRO® Sale in Finland to Turku University Hospital
March 20, 2017, Press Release
OTC Market Groups Welcomes Profound Medical to OTCQX
March 13, 2017, OTC Press Release
Profound Medical Corp. to Begin Trading on OTCQX on March 13, 2017
March 9, 2017, Press Release
Profound Medical Corp. Announces Fourth Quarter and Full Year 2016 Financial Results
March 6, 2017, Press Release
Profound Medical Corp. to Release Fourth Quarter and Full Year 2016 Financial Results on March 6, 2017 – Conference Call to Follow
February 21, 2017, Press Release
Profound Medical to Participate in 2017 BTIG Medical Technology, Life Science and Diagnostic Tools Conference
February 14, 2017, Press Release
Profound Medical Announces Special Meeting of Shareholders Voting Results
January 26, 2017, Press Release
Kenneth Galbraith joins Profound Medical Board
January 18, 2017, BioTuesdays
Profound Medical Announces Appointment of Kenneth Galbraith to its Board of Directors
January 17, 2017, Press Release
